Cargando…

Correction to: An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 Infection

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361169/ https://www.ncbi.nlm.nih.gov/pubmed/35959209 http://dx.doi.org/10.1093/ofid/ofac412

Ejemplares similares

An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 Infection
por: Scher, Ann I, et al.
Publicado: (2022)

The recency and geographical origins of the bat viruses ancestral to SARS-CoV and SARS-CoV-2
por: Pekar, Jonathan E., et al.
Publicado: (2023)

Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study
por: Hensley, Kathryn S., et al.
Publicado: (2023)

Author Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents
por: Rosa Duque, Jaime S., et al.
Publicado: (2022)

Immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccines in healthy adults
por: Wu, Yufei, et al.
Publicado: (2023)

Correction: SARS-CoV-2 vaccines in patients with SLE
Publicado: (2021)

Correction to: HD5 and LL‑37 Inhibit SARS‑CoV and SARS‑CoV‑2 Binding to Human ACE2 by Molecular Simulation
por: Li, Daixi, et al.
Publicado: (2021)

Correction to: Transmission Cycle of SARS-CoV and SARS-CoV-2
por: Yadav, Tushar, et al.
Publicado: (2020)

Correction: Immunoinformatics approach of epitope prediction for SARS-CoV-2
por: Awad, Nourelislam, et al.
Publicado: (2022)

Correction: SARS-CoV-2 infection in China—Before the pandemic
por: Liang, Huiying, et al.
Publicado: (2022)

Neutralizing Antibodies against SARS-CoV-2, Anti-Ad5 Antibodies, and Reactogenicity in Response to Ad5-nCoV (CanSino Biologics) Vaccine in Individuals with and without Prior SARS-CoV-2
por: Hernández-Bello, Jorge, et al.
Publicado: (2021)

Correction for Xiong et al., The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2
Publicado: (2022)

Comparison of immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccine (CoronaVac) in previously SARS-CoV-2 infected and uninfected health care workers
por: Soysal, Ahmet, et al.
Publicado: (2021)

Correction: Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins
por: Emmenegger, Marc, et al.
Publicado: (2022)

Prior SARS-CoV-2 infection increases reactogenicity after SARS-COV-2 mRNA vaccine and could delay the administration of the vaccine based on timing of infection
por: Stellini, Roberto, et al.
Publicado: (2021)

Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study
por: Naranbhai, Vivek, et al.
Publicado: (2022)

Author Correction: Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
por: Ou, Xiuyuan, et al.
Publicado: (2021)

Correction to: The role of passive immunization in the age of SARS-CoV-2: an update
por: Fischer, Johannes C., et al.
Publicado: (2020)

Correction: Role of the early secretory pathway in SARS-CoV-2 infection
por: Sicari, Daria, et al.
Publicado: (2020)

Correction to: Genome evolution of SARS-CoV-2 and its virological characteristics
por: Nakagawa, So, et al.
Publicado: (2020)

Correction to: SARS-CoV-2 removal with a polyurethane foam composite
por: Schoeler, Guilherme Pereira, et al.
Publicado: (2022)

Correction to: Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections
por: Huber, Timo, et al.
Publicado: (2021)

Author Correction: Characteristics of SARS-CoV-2 and COVID-19
por: Hu, Ben, et al.
Publicado: (2022)

Correction to: Environmental Integrants Affecting the Spreadability of SARS‑CoV‑2
por: Islam, Muhammad Torequl
Publicado: (2021)

Correction to: Titers of SARS CoV-2 antibodies in cord blood of neonates whose mothers contracted SARS CoV-2 (COVID-19) during pregnancy and in those whose mothers were vaccinated with mRNA to SARS CoV-2 during pregnancy
por: Kashani-Ligumsky, Lior, et al.
Publicado: (2021)

SARS-CoV-2 BNT162b2 vaccine–induced humoral response and reactogenicity in individuals with prior COVID-19 disease
por: Kelsen, Steven G., et al.
Publicado: (2022)

Characterization of adolescents with functional respiratory disorders and prior history of SARS-CoV-2
por: Bode, Sebastian Felix Nepomuk, et al.
Publicado: (2023)

Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot® Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals
por: Mak, Willem A., et al.
Publicado: (2022)

Transmission Cycle of SARS-CoV and SARS-CoV-2
por: Yadav, Tushar, et al.
Publicado: (2020)

Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
por: Goyal, Rajat, et al.
Publicado: (2022)

Correction: SARS-CoV-2 in the Amazon region: A harbinger of doom for Amerindians
por: Ramírez, Juan David, et al.
Publicado: (2021)

Correction to: Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains
por: Padron-Regalado, Eriko
Publicado: (2020)

Author Correction: Mechanical activation of spike fosters SARS-CoV-2 infection
por: Hu, Wei, et al.
Publicado: (2021)

Correction: Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)?
por: Liu, Ping, et al.
Publicado: (2021)

Correction: Mapping and role of T cell response in SARS-CoV-2–infected mice
por: Zhuang, Zhen, et al.
Publicado: (2021)

Correction to: Detection of SARS‑CoV‑2 variants in India from UK returnees
por: Potdar, Varsha, et al.
Publicado: (2021)

Correction to: Repeat SARS-CoV-2 testing models for residential college populations
por: Chang, Joseph T., et al.
Publicado: (2021)

Correction: SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
por: Ferreira, André C., et al.
Publicado: (2021)

Correction: Current status of therapeutic monoclonal antibodies against SARS-CoV-2
por: Kumar, Sanjeev, et al.
Publicado: (2022)

Correction: The Rise of SARS-CoV-2 (COVID-19) Omicron Subvariant Pathogenicity
por: DeGrasse, David C, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v8nbqrrb94gomr3iegptr6cu8f